Skip to main content

Published locations for FDA expands abemaciclib use in high-risk early breast cancer

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. FDA expands abemaciclib use in high-risk early breast cancer

User login

  • Reset your password
  • /content/fda-expands-abemaciclib-use-high-risk-early-breast-cancer
  • /familypracticenews/article/261640/breast-cancer/fda-expands-abemaciclib-use-high-risk-early-breast
  • /fedprac/article/261640/breast-cancer/fda-expands-abemaciclib-use-high-risk-early-breast-cancer
  • /internalmedicinenews/article/261640/breast-cancer/fda-expands-abemaciclib-use-high-risk-early-breast
  • /obgynnews/article/261640/breast-cancer/fda-expands-abemaciclib-use-high-risk-early-breast-cancer
  • /oncologypractice/article/261640/breast-cancer/fda-expands-abemaciclib-use-high-risk-early-breast
  • /fedprac/avaho/article/261640/breast-cancer/fda-expands-abemaciclib-use-high-risk-early-breast-cancer
  • /obgyn/article/261640/breast-cancer/fda-expands-abemaciclib-use-high-risk-early-breast-cancer
  • /hematology-oncology/article/261640/breast-cancer/fda-expands-abemaciclib-use-high-risk-early-breast
  • /internalmedicine/article/261640/breast-cancer/fda-expands-abemaciclib-use-high-risk-early-breast
  • /familymedicine/article/261640/breast-cancer/fda-expands-abemaciclib-use-high-risk-early-breast
  • /breast-cancer-icymi/article/261640/breast-cancer/fda-expands-abemaciclib-use-high-risk-early-breast